Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ty23991
    Member
    • May 2015
    • 24

    Germline variant calling using tumor-normal pairs in GATK

    Hi
    i have tumor normal pairs and am interested in calling germline variants. The GATK UnifiedGenotyper does seem to call the germline variants as it does not require normal/tumor input arguments.

    I don't think there are any options in GATK.

    Apart from varscan2, what other tools can be used for germline calling based on tumor-normal pairs ?

    And which one performs the best ?
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    The GATK based option is MuTect: https://www.broadinstitute.org/cancer/cga/mutect

    Comment

    • ty23991
      Member
      • May 2015
      • 24

      #3
      Mutect is good for somatic variant calls, not the germline.

      Comment

      • Bukowski
        Senior Member
        • Jan 2010
        • 388

        #4
        Er it calls the tumour and normal precisely to separate the somatic from the germline variants.. that's the whole point of doing tumour/normal calling right?

        If you only want to call the germline mutations - just use GATK anyway and remove your variants identified as somatic elsewhere. I'm surprised MuTect doesn't output somatic and germline.
        Last edited by Bukowski; 07-01-2016, 05:22 AM.

        Comment

        • ty23991
          Member
          • May 2015
          • 24

          #5
          Yes. I agree. But I m not sure what filters can I use for the germline variants .

          Comment

          • ty23991
            Member
            • May 2015
            • 24

            #6
            Originally posted by Bukowski View Post
            Er it calls the tumour and normal precisely to separate the somatic from the germline variants.. that's the whole point of doing tumour/normal calling right?

            If you only want to call the germline mutations - just use GATK anyway and remove your variants identified as somatic elsewhere. I'm surprised MuTect doesn't output somatic and germline.
            I checked my unfiltered vcf files but could not find any with normal and tumor both with mutant genotype. So mutant does not seem to output germline at all.

            Mutect also uses a filtering criterion called "germline risk variant" but that's not the actual germline variant call.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            32 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            43 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            29 views
            0 reactions
            Last Post SEQadmin2  
            Working...